EIKN

Eikon Therapeutics is a biopharmaceutical company focused on discovering and developing novel treatments for life-threatening diseases. The company utilizes advanced microscopy and computational biology to study protein dynamics in living cells, enabling drug discovery at unprecedented resolution. Eikon's platform technology allows researchers to observe and analyze cellular processes in real-time, identifying potential therapeutic targets. The company is developing a pipeline of small molecule therapeutics aimed at addressing significant unmet medical needs in oncology and other serious conditions.